Albert J Yee Selected Research

Versicans (Versican)

5/2013	The role of versican in modulating breast cancer cell self-renewal.
3/2013	Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.
1/2013	Versican V2 isoform enhances angiogenesis by regulating endothelial cell activities and fibronectin expression.
1/2013	Roles of versican in cancer biology--tumorigenesis, progression and metastasis.
8/2012	The role of versican G3 domain in regulating breast cancer cell motility including effects on osteoblast cell growth and differentiation in vitro - evaluation towards understanding breast cancer cell bone metastasis.
1/2011	Versican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapy.
11/2010	Versican G3 promotes mouse mammary tumor cell growth, migration, and metastasis by influencing EGF receptor signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert J Yee Research Topics

Disease

11	Neoplasms (Cancer) 03/2022 - 11/2010
8	Breast Neoplasms (Breast Cancer) 03/2022 - 11/2010
4	Neoplasm Metastasis (Metastasis) 03/2013 - 11/2010
1	Ascites 03/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Wounds and Injuries (Trauma) 05/2013
1	Liver Neoplasms (Liver Cancer) 03/2013
1	Hepatocellular Carcinoma (Hepatoma) 03/2013
1	Glioblastoma (Glioblastoma Multiforme) 01/2013
1	Brain Neoplasms (Brain Tumor) 01/2013
1	Carcinogenesis 01/2013

Drug/Important Bio-Agent (IBA)

7	Versicans (Versican)IBA 05/2013 - 11/2010
3	Circular RNAIBA 03/2022 - 12/2018
3	MicroRNAs (MicroRNA)IBA 03/2013 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 12/2018 - 03/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 03/2013 - 11/2010
2	Epidermal Growth Factor (EGF)IBA 03/2013 - 08/2012
2	Proteoglycans (Proteoglycan)IBA 01/2013 - 01/2013
1	IntegrinsIBA 03/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 05/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 03/2013
1	Tyrosine (L-Tyrosine)FDA Link 03/2013
1	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 03/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 03/2013
1	Competitive Endogenous RNAIBA 03/2013
1	Protein Isoforms (Isoforms)IBA 01/2013
1	ChondroitinIBA 01/2013
1	Dermatan SulfateIBA 01/2013
1	ergosterol-5,8-peroxideIBA 01/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2011
1	N-acetylsphingosineIBA 01/2011
1	Bovine Serum AlbuminIBA 01/2011
1	Conditioned Culture MediaIBA 01/2011
1	Epirubicin (Ellence)FDA LinkGeneric 01/2011
1	RTKI cpdIBA 11/2010

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2012 - 01/2011
1	Therapeutics 01/2011